Predicting the ovarian reserve and success in ART cycles is necessary in planning the treatment schedules, preventing OHSS and advising the couple. The present study aims to validate the reliability of AMH estimation as predictor of fertility potential of the woman. This is a retrospective analysis of the success of the multiple IVF/ICSI cycles on one hundred women at an Infertility centre, all the protocols, procedures done by the same team. 20 women had high, 23 had low and 57 had normal AMH. All women with normal AMH had good ovarian response; in women with high AMH all woman except one had good ovarian response; all women with low AMH had poor ovarian response. 128 cycles of IVF/ICSI were performed on hundred women, 184 embryo transfers were done with fresh and cryopreserved embryos, with clinical pregnancy in 49 women. In 57women with normal AMH in 76 ART cycles, 123 embryo transfers, 39 clinical pregnancies occurred; in 20 women with high AMH in 28 ART cycles, 44 embryo transfers, 9 had clinical pregnancy; in 23 women with low AMH in 24 ART cycles, 17 embryo transfers, only one became pregnant.
Introduction
AMH is a dimeric glycoprotein. During reproductive age AMH is secreted by granulosa cells of preantral and small antral follicles in the ovary. It is expressed as early as 36 weeks of gestation. According to the pattern of AMH secretion, serum level of AMH can show the age and storage of the ovary. Evaluation of ovarian storage is an essential step for treatment of infertility. There are several methods for evaluation of ovarian storage such as Antral follicle count which is done by transvaginal ultrasound on day 2 of cycle. Other methods are serum Oestrogens, Follicle stimulating hormone and Inhibin levels. AMH has an important advantage over FSH as it can be reliably measured at any stage of the menstrual cycle unlike FSH which requires www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i9.53 venous sampling on the day 2 or day 3 of menses and baseline FSH levels fluctuate from cycle to cycle. Serum AMH is not affected by consumption of oral contraceptive pills unlike serum levels of FSH and other markers. Normal level of AMH blood level is 1.5-4.0 ng/ml. The Aim of the study is to determine the predictive value of AMH as a marker of ovarian reserve
Material and Methods
A total number of 100 patients of less than 40 years of age referred to an IVF Clinic who underwent IVF/ICSI using either GnRH agonist/ GnRH antagonist protocol during theperiod April 2016 to April 2018 were studied by retrospective analysis. On day 2 of menstrual cycle blood sample was obtained for measuring serum AMH, FSH, Oestradiol and Transvaginal ultrasound examination to assess the number of antral follicles [2-5 mm] was done. A standard down regulation long protocol using GnRH Agonist or Antagonist protocol was used.HCG was administered when more than 3 follicles more than 18 mm were reached. Oocyte retrieval was done after 34-36 hours.2 or 3 embryos were transferred on day of 3 of fertilization and rest of the embryos were freezed and transferred in subsequent cycles. The study group was divided into three subgroups according to AMH levels. Maximum patients i.e.57% had normal AMH, 20% had high AMH and 23% had low AMH. In the present study of 100 patients, 11% were in the age group of 21-25 years, 20% were in the age group of 26-30 years, 51% were in the age group of 31-35 years and 18% were in the age group of 36-40 years. Patients with Oocyte count four or more were considered good responders and patients with less than four as poor responders. In present study 76% were good responders who had normal AMH and high AMH values whereas 24% were poor responders who had low AMH values. In this study of 100 patients--57 patients had normal AMH, total no of oocytes retrieved were 586, 498 embryos were fertilised, all 57 patients had embryo transfer on day 3 after Oocyte retrieval in the same cycle. Freezing of the embryos were done in those patients who had more than three embryos and transfer was done in the second cycle. In this study 38 patients with normal AMH had second cycle of frozen embryo transfer. In 57 patients with normal AMH we observed 32 clinical pregnancies in 95 cycles of transfer.
Results
144 Oocytes were retrieved in 20 patients with high AMH, embryos fertilised were 74. All the 20 patients with high AMH had first cycle of embryo transfer, second cycle of frozen embryo transfer was done in 12 patients. Total number of clinical pregnancies were 8. In 23 patients with low AMH, 70 Oocytes were retrieved,28 embryos were fertilised. Embryo transfer was done in the same cycle in 16 patients. In 7 patients embryo transfer was not done because of poor response to stimulation and poor Oocyte quality. In 7 high AMH patients, 52 Oocytes were retrieved and 31 embryos were fertilised, all the 7 patients had transfer in the same cycle, 3 patients had second cycle transfer also. Total number of clinical pregnancies were 1. In 1 patient with low AMH, 2 Oocytes were retrieved and 1 was fertilised and transferred in the same cycle, there was no clinical pregnancy. High  20  144  74  20  12  8  Normal  57  586  498  57  38  32  Low  23  70  28  16  -1 Ae van Rooj et al, 2005; Robertson et al, 2008 found that reduction in ovarian reserve is a physiological process occurring in the late reproductive period and consistently associated with a decrease in AMH levels and low antral follicle count.
In 20 PCOS patients it was observed that AMH levels were high >4ng/ml and increased follicular count which can be used for predicting hyper response and risk of OHSS so that Gonadotropins doses can be adjusted. Four prospective studies which were performed [Kwee et al., 2007 , Nelson et al., 2007 , Lee et al 2008 , Nardo et al.,2008 
Conclusion
Serum AMH is a potential reliable marker in predicting ovarian reserve and reproductive performance. Along with antral follicle count it is a better predictor than serum FSH. In women with PCOS AMH can be used as a diagnostic and prognostic marker for ovarian response and hyperstimulation and alter the stimulation protocol to prevent OHSS. It is a good predictor of poor response to fertility treatment and to plan the treatment accordingly.
